RUBIN PAUL D 内部人交易：近期 SEC Form 4 交易
过去 18 个月，RUBIN PAUL D（CIK 1210905）在 1 家公司共报告 16 笔 SEC Form 4 内部人交易（最近一笔 2026-04-03）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-04-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | 买入 | 5,437 | $22,346 |
| 2026-04-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | 买入 | 3,383 | $22,226 |
| 2026-04-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | 卖出 | 8,820 | $157,084 |
| 2026-03-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | 买入 | 5,433 | $22,330 |
| 2026-03-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | 买入 | 2,000 | $13,140 |
| 2026-03-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | 卖出 | 7,433 | $150,890 |
| 2026-02-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | 买入 | 5,433 | $22,330 |
| 2026-02-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | 买入 | 2,000 | $13,140 |
| 2026-02-03 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | 卖出 | 7,433 | $139,369 |
| 2026-01-06 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | 买入 | 5,433 | $22,330 |
| 2026-01-06 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | 买入 | 2,000 | $13,140 |
| 2026-01-06 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | 卖出 | 7,433 | $95,514 |
| 2025-12-11 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | 买入 | 18,000 | $118,260 |
| 2025-12-11 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | 卖出 | 18,000 | $216,000 |
| 2025-12-05 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | 买入 | 68,897 | $283,167 |
| 2025-12-05 | BioAge Labs, Inc. (BIOA) | Chief Medical Officer | 卖出 | 68,897 | $702,060 |
来源：SEC Form 4 申报文件 · 截至 2026-04-03